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background: Two-third of patients who received cardiac resynchronization therapy (CRT) is classified as responders. However, the 
response to CRT would be transient and beneficial effect would diminish during long-term follow up in some of responders. We termed 
these patients transient responders (TR), and analyzed their proportion, predictors, and prognosis of TRs.
Methods and results:  Five-hundred and twenty eight CRT patients with echocardiographic data at baseline (pre-CRT implantation), 6 
months and 1 and/or 2 years after implantation were enrolled in this analysis from CUBIC registry (multi-center study of CRT) database. 
We defined CRT responders as those with reduction of LV end-systolic volume (LVESV) estimated by Simpson method at 6 months by 
more than 15% compared with baseline. We also defined TR as the CRT responders whose LVESV at 1-2 years follow-up increased or 
decreased by less than 15% compared with baseline. We found 328 patients (62%) were CRT responders, and 50 patients (15%) of those 
were TR. We performed multivariable analysis to identify predictors of TR among the CRT responders, and revealed that 3 variables were 
independently associated with TR: sustained ventricular tachycardia/fibrillation (VT/VF) episode (odds ratio: 3.06; 95% confident interval: 
1.38 - 6.75), non-LBBB intrinsic QRS pattern (2.10; 1.09 - 4.07), history of heart failure (HF) hospitalization (2.82, 1.04 - 7.67). Then, we 
investigated the prognosis of TR and compared it with that of persistent responders (PR, N=278), whose LVESV reduction was more than 
15% at both 6 months and 1 and/or 2 year follow-up, and non-responders (NR, N=200), whose LVESV reduction was less than 15% at 6 
months. We found that the incidence of cardiac death and HF hospitalization was significantly higher in TR than in PR (TR vs. PR, 46.0% 
vs. 19.8%, p<0.01), and as high as that in NR (TR vs. NR, 46.0% vs. 49.5%, p=0.75).
Conclusion:  The good response to CRT would be transient in 15% of CRT responders, and history of VT/VF, non-LBBB QRS morphology, 
and history of HF hospitalization were the predictors of transient response to CRT. The prognosis of TR was worse than that of PR and 
almost same as that of NR.
